Study reveals a key to blood vessel growth and possible d...(the molecular basis of how endothelial c...)
Navigation Links
Study reveals a key to blood vessel growth and possible drug target
Date:10/14/2007
the molecular basis of how endothelial cell-related pathologies such as cancer, diabetic eye complications, known as retinopathies, atherosclerosis and system lupus develop, Santoro said. It can also help us design new therapeutic strategies for these diseases.
The team hopes that future researchers will investigate other avenues and alternative pathways. Because vascular health impacts many different diseases, understanding how to genetically control endothelial cell survival and apoptosis is critical to future work in these areas, Stainier said.
'/>"/>
| Contact: Jennifer O'Brien jobrien@pubaff.ucsf.edu 415-476-2557 University of California - San Francisco Source:Eurekalert |
Related biology news :
1. Bioartificial kidney under study at MCG
2. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
3. W.M. Keck Foundation funds study of friendly microbes
4. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
5. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
6. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
7. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
8. Study Links Ebola Outbreaks To Animal Carcasses
9. Genome-wide mouse study yields link to human leukemia
10. Breakthrough Microarray-based Technology for the Study of Cancer
11. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
Post Your Comments:
Breaking Biology News(10 mins):Old hay and Alpine ibex horns reveal how grasslands respond to climate change 2Old hay and Alpine ibex horns reveal how grasslands respond to climate change 3Charles Darwin: More than the origin 2Charles Darwin: More than the origin 3Scripps Research team uncovers chemical basis for extra 'quality control' in protein production 2Scripps Research team uncovers chemical basis for extra 'quality control' in protein production 3Scripps Research team uncovers chemical basis for extra 'quality control' in protein production 4Blue Cross and Blue Shield of Floridas Power of the Human Voice Campaign Wins Prestigious DMA International ECHO Gold Award 60266 1Blue Cross and Blue Shield of Floridas Power of the Human Voice Campaign Wins Prestigious DMA International ECHO Gold Award 60266 2NIEHS awards Recovery Act funds to address bisphenol A research gaps 10565 1NIEHS awards Recovery Act funds to address bisphenol A research gaps 10565 2NIEHS awards Recovery Act funds to address bisphenol A research gaps 10565 3NIEHS awards Recovery Act funds to address bisphenol A research gaps 10565 4NIEHS awards Recovery Act funds to address bisphenol A research gaps 10565 5NIEHS awards Recovery Act funds to address bisphenol A research gaps 10565 6NIEHS awards Recovery Act funds to address bisphenol A research gaps 10565 7NIEHS awards Recovery Act funds to address bisphenol A research gaps 10565 8New Clues to How Fish Oils Help Arthritis Patients 60263 1New Clues to How Fish Oils Help Arthritis Patients 60263 2
Other Biology News:Female concave-eared frogs draw mates with ultrasonic calls 2Female concave-eared frogs draw mates with ultrasonic calls 3Neurotechnology Announces MegaMatcher 2.1 SDK for Development of Large-scale AFIS and Multi-biometric Face-Fingerprint Identification Systems 2Neurotechnology Announces MegaMatcher 2.1 SDK for Development of Large-scale AFIS and Multi-biometric Face-Fingerprint Identification Systems 3Neurotechnology Announces MegaMatcher 2.1 SDK for Development of Large-scale AFIS and Multi-biometric Face-Fingerprint Identification Systems 4BIO-key(R) Announces First Quarter 2008 Earnings Release and Conference Call Schedule 2
Breaking Biology Technology:Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6Sirius Genomics Announces Change in Leadership 2
[0] Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner [0] Quest Diagnostics Declares Quarterly Cash Dividend[0] Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain[0] Sirius Genomics Announces Change in Leadership
Other Biology Technology:Patients Fail to Take Fake Medicines Risk Seriously 2Patients Fail to Take Fake Medicines Risk Seriously 3Varian Medical Systems Sponsors Special Broadcast of The Group Room(R), a Live Radio Talkshow About Cancer 2Varian Medical Systems Sponsors Special Broadcast of The Group Room(R), a Live Radio Talkshow About Cancer 3Favrille to Present at BIOCOM Investor Conference, Acumen BioFin Rodman & Renshaw Healthcare Conference and CIBC World Markets Healthcare Conference 2
Patients Fail to Take Fake Medicines Risk SeriouslyVarian Medical Systems Sponsors Special Broadcast of The Group Room(R), a Live Radio Talkshow About CancerFavrille to Present at BIOCOM Investor Conference, Acumen BioFin Rodman & Renshaw Healthcare Conference and CIBC World Markets Healthcare Conference
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |